Accessibility overlays promise something deeply appealing: instant compliance, minimal effort, and legal protection.
Add a line of JavaScript. Turn on a widget. Declare your website accessible.
Unfortunately, reality tells a very different story.
Across industries—including healthcare and life sciences—accessibility overlays are not only failing to make websites accessible, they are increasingly cited in lawsuits as evidence of inaccessibility. Courts, regulators, and accessibility experts are aligned on one point:
Overlays are not accessibility. And they are not legal protection.
Myth #1: “Accessibility Overlays Make a Website ADA Compliant”
Reality: No court has accepted an accessibility overlay as proof of ADA compliance.
Legal data shows that sites using overlays are sued at the same or higher rates than sites without them, and lawsuits frequently cite overlays as part of the problem, not the solution. [ratedwithai.com], [accessibility.works]
In 2024 alone:
- Over 25% of ADA website lawsuits explicitly targeted sites using overlays
- Courts routinely required removal of overlays as part of settlements
- Judges emphasized that compliance depends on underlying code, not add‑on tools [accessibility.works], [testparty.ai]
Accessibility law focuses on results, not widgets.
Myth #2: “Overlays Fix Accessibility Issues Automatically”
Reality: Overlays do not fix the source code—and assistive technologies read source code.
Screen readers and other assistive tools parse a site’s HTML before overlay scripts execute. That means missing labels, broken headings, poor keyboard navigation, and structural WCAG failures remain unchanged. [testparty.ai], [dev.to]
Expert analysis shows overlays:
- Cannot repair semantic structure
- Cannot correctly associate form labels
- Cannot fix keyboard focus order
- Often interfere with users’ existing assistive technology settings [testparty.ai], [brickfield.ie]
In short: they mask problems visually while leaving barriers intact.
Myth #3: “Overlays Reduce Legal Risk”
Reality: Overlays are now a litigation signal.
Multiple reports show plaintiff firms actively targeting overlay‑using websites because:
- Violations are easy to identify
- Overlay claims of “full compliance” are legally vulnerable
- Courts consistently reject overlays as remediation [scancomply.com], [accessibility.works]
In January 2025, the FTC fined a major overlay provider $1 million for deceptive claims, stating that marketing overlays as making sites ADA compliant was misleading. [scancomply.com]
That enforcement action validated what accessibility advocates and legal experts have warned for years.
Myth #4: “The DOJ Endorses Overlays”
Reality: The Department of Justice does not endorse overlays.
In its ADA Title II rulemaking, the DOJ explicitly emphasized outcomes over technologies, stating that accessibility must meet WCAG 2.1 Level AA standards, regardless of tools used. [ada.gov], [w3.org]
The DOJ cited W3C community research that documents the limitations of post‑source tools, including overlays, reinforcing that accessible results—not shortcuts—are required. [w3.org]
Why This Matters for Pharma Customer Experience
In healthcare and life sciences, inaccessible digital experiences are not just legal risks—they are barriers to care.
Overlays create:
- False confidence for organizations
- Frustration for people with disabilities
- Increased exposure to litigation
- Erosion of trust at critical moments in the patient journey
Accessibility cannot be bolted on after the fact. It must be designed into the experience—from content structure and navigation to forms, media, and workflows.
What Actually Works
Organizations that reduce legal risk and improve accessibility do the following:
- Remediate source code to WCAG standards
- Test with real assistive technologies and users
- Train teams so accessibility is sustained—not patched
- Treat accessibility as customer experience quality, not a compliance add‑on [info.usablenet.com], [blog.usablenet.com]
This approach is harder than installing a widget—but it’s the only one that works.
The Bottom Line
Accessibility overlays sell convenience.
Courts demand compliance.
Users need usability.
For Pharma customer experience leaders, the message is clear:
There are no shortcuts to accessibility—and pretending otherwise increases risk for everyone.
At mclassiter.com, we believe accessibility is not a feature you turn on.
It is a commitment you build into how experiences work—for real people, in real conditions.
Selected References
- UsableNet ADA Lawsuit Reports [info.usablenet.com], [blog.usablenet.com]
- FTC Enforcement Action on Overlay Marketing [scancomply.com]
- DOJ ADA Title II Web Accessibility Rule [ada.gov]
- TestParty & W3C Overlay Analysis [testparty.ai], [w3.org]
- Lainey Feingold Legal Update on Overlays [lflegal.com]
